Form 4: Protagonist Therapeutics CEO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Protagonist Therapeutics CEO, Dinesh V. Patel, sold 12,636 shares to cover tax obligations related to the settlement of restricted stock units.
Summary
- Dinesh V. Patel, the President and CEO of Protagonist Therapeutics, sold 12,636 shares of common stock on January 15, 2025.
- The sale was executed to cover tax withholding obligations associated with the settlement of restricted stock units.
- Following the transaction, Mr. Patel directly owns 545,619 shares of Protagonist Therapeutics common stock.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction for tax purposes, which is neither positive nor negative for the company's outlook. The sentiment is neutral to slightly positive as it indicates the CEO is receiving stock-based compensation.
Industry Context
This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.
Comparison to Industry Standards
- Executive stock sales to cover tax obligations are a common practice across publicly traded companies.
- The number of shares sold is relatively small compared to the total holdings of the CEO, suggesting this is a routine tax-related transaction rather than a significant divestment.
- Similar transactions are regularly reported by executives at comparable biotech companies.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine sale for tax purposes.
- The sale does not indicate any change in the CEO's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 01/15/2025 | Date of the stock sale transaction. |
| 01/17/2025 | Date the form was signed by the attorney-in-fact. |
Keywords
Protagonist Therapeutics, Dinesh V. Patel, stock sale, tax obligations, restricted stock units, insider trading, executive compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.